Company:  ZEALAND PHARMA A/S (ZEAL)
Form Type:  6-K
Filing Date:  10/12/2017 
CIK:  0001674988 
Address:  SMEDELAND 36
2600 GLOSTRUP
 
City, State, Zip:  COPENHAGEN,  00000 
Telephone:  (458) 877-3600 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$14.80  
Change: 
0.11 (0.75%)  
Trade Time: 
Jun 18  
Market Cap: 
$455.12M
Trade ZEAL now with 

© 2018  
Description of Business
We were founded in 1998 and is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. We intend to be a leader in specialty medicines focusing on metabolic and gastrointestinal diseases and other specialty disease areas with significant unmet medical needs. We have a portfolio of medicines and product candidates under license collaborations with Sanofi and Boehringer Ingelheim. Our pipeline focuses on gastrointestinal, metabolic and other specialty diseases where we believe that the present standard of care is inadequate and where we have the resources to advance our peptide-based product candidates into the later stages of clinical development, including registration and commercialization, while opportunistically considering partnership relationships that may arise. We have a track record of successfully inventing and developing novel peptide-based product candidates.
Register and access this filing in:     
  FORM 6-K
    SIGNATURE
  EXHIBIT 99.1